Various studies have linked variations in cytokine and cortisol levels in MDD [10]; one of the first studies of the neuromodulatory effects of cytokines reported the induction of depressive symptoms by therapeutic IL-2 and IFNs [11]. The gene discussed is IL2; the disease is major depressive disorder.